Woyce
Non-human identities—service accounts, API keys, bots, and AI agents—now vastly outnumber human users in most enterprises, and most security programs still aren't built to manage them.
A closer look at how tool poisoning attacks exploit the Model Context Protocol, why they matter for any team connecting AI agents to external tools, and how to defend against them.
AI agents don't fit the assumptions perimeter security and static IAM were built on. This piece explains why zero trust is being re-architected around autonomous, non-human actors.
AI browser agents can click, type, and submit forms on your behalf, but that same autonomy creates a new attack surface where a webpage itself can hijack the agent's actions.
A look at how AI systems now discover software vulnerabilities before attackers do, how the pipeline actually works, and what changed when that capability turned up in criminal hands.
A plain-language look at how AI voice cloning powers modern vishing attacks, why security teams now rank it among the top initial access vectors, and how organizations can defend against it.
A practical breakdown of the technologies behind online age verification, from ID scans and facial age estimation to third-party age tokens, and why they're becoming mandatory.
A plain-language guide to the EU Digital Identity Wallet under eIDAS 2.0: how it works, who has to accept it, and what it means for businesses building identity and payment flows in Europe.
A look at how generative AI models like GNoME and MatterGen flip materials science on its head—starting from a desired property and generating a crystal structure to match, instead of testing compounds one at a time.
Self-driving labs pair AI planning agents with robotic experimentation to design, run, and interpret scientific experiments in a closed loop, with little or no human intervention.
A practical breakdown of how machine learning weather models like GraphCast, GenCast, and ECMWF's AIFS predict the atmosphere faster and often more accurately than traditional physics simulations.
A grounded look at how many AI-originated drugs are actually in clinical trials, how they're performing, and why zero have reached full FDA approval.